益處
• 促進正常的骨質密度
• 促進動脈健康
• 支援免疫系統健康
• 有助維持骨骼健康
• 有助維持正常蝕骨細胞活動以支援骨質密度
• 幫助維持心血管健康
• 促進血管彈性
• 或有助於穩定血壓*
• 骨質密度低的女性獲發現出缺乏維他命D
*此產品沒有根 據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲明亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。
產品分類
不含麩質 - 本產品不含可檢測出之麩質*
不含可檢測出之基改成份(GMO) - 本產品不含可檢測出之基因改造生物成份
素食品 - 本產品為素食產品
等滲壓營養補充沖飲 - 易於飲用的營養補充品 / 健康食品,透過等滲壓狀態達致更佳的營養吸收
品質標準 - 良好生產規範(GMP)運作與標準化成份
已檢測:重金屬丶微生物污染物丶過敏原丶效力丶純度及特性
*美國食品藥品監督管理局(FDA)將含有少於20PPM麩質的製成產品列為不含麩質
詳細資料
Isotonix維他命D+K2沖飲含有維他命D3,是具代謝活性形式的維他命D,並含有維他命K2,是一種支援血管健康和鈣質運用的維他命K。維他命D對於骨骼健康、心臟健康和免疫支援均有重要作用;與維他命K一同使用,能支援鈣的正常吸收並促進動脈健康。
Isotonix維他命D+K2沖飲是首個以等滲壓方式同時提供兩種強效維他命的產品。Isotonix維他命D+K2沖飲中加入維他命K,因為維他命K和D配合使用成效顯著,可共同支援鈣的吸收和運用。維他命K支援鈣質正常輸送到骨骼,並促進動脈健康。現時已發現了至少兩種以天然形式存在的維他命K,名為K1和K2。雖然這兩種維他命K形式有許多相似之處,但也有一些重要的區別。
維他命K1和K2最顯著的區別在於其化學結構,使它們具有不同的藥代動力學的特性。維他命K1主要儲存在肝臟中,高劑量的K1可能會干擾薄血丸和其他抗凝血藥物的作用。維他命K2的作用機制有別於K1,它主要被輸送至骨骼和血管。維他命K2有助維持骨質密度、支援鈣的運用和促進血管彈性。研究表示維他命K2不會對凝血藥物造成影響。不過,大多數含有維他命K(包括K1及/或K2)的產品都有警告標示,提醒服用抗凝血藥物人士不要使用此類產品。如果你正在服用薄血丸或其他抗凝血藥物,在使用任何含有維他命K1或K2的產品前,請先諮詢你的醫護人員。
了解更多
Isotonix®輸送系統
成份
維他命D3(膽鈣化醇)
維他命D屬於脂溶性的維他命,存在於某些食物當中,並在太陽照射到皮膚時,在體內自動產生。維他命D促進腸道更有效率地吸收鈣質,主要在十二指腸與空腸內,促進鈣結合蛋白的合成,以支援鈣質正常吸收及保留。維他命D亦促進骨骼正常生成及生長,並且透過成骨細胞與蝕骨細胞促進骨骼再生。
缺乏維他命D的原因可能包括缺乏日照、減少維他命D的皮膚合成、來自飲食的攝取量較低、腸道吸收不良、以及腎臟降低維他命D的新陳代謝與活性,這些原因皆會隨著老化而增加。缺乏維他命D與多種健康風險有關,還包括骨骼脆弱和肌肉無力。除了促進強健骨骼外,維他命D在健康方面還有其他作用,包括支援身體神經肌肉功能和免疫功能的正常調節。維他命D已證實能支援免疫調節,同時,透過補充維他命D能促進身體正常調節T細胞功能,以促進免疫健康。關於細胞健康方面,維他命D支援許多基因的調節,這些基因是負責蛋白質編碼,以調節正常細胞週期活動。體內維他命D的含量與細胞健康密切相關。最後,維他命D通過與VDR(維他命D受體)的相互作用,支援基因編碼腎素的健康運作,從而或有助於穩定血壓*。
*此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲明亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。
維他命K2(甲萘醌-7)
維他命K是一種脂溶性維他命,存在於肉類、蛋類、奶製品和納豆中。雖然維他命K2是一種脂溶性維他命,但人體只能儲存極少量;如果不透過恆常膳食攝取,體內儲存的維他命K2會迅速耗盡。天然的維他命K2,又稱為甲萘醌-7 (MK-7),是最具生物可利用性的維他命K形態,其在血液中的半衰期比其他形式的維他命K長。日本大豆食品的納豆,含有特別豐富的甲萘醌-7 (MK-7)。有關日本人進食納豆的研究發現,甲萘醌-7與骨骼和心血管健康有所相關。此關聯之重點在於維持適當地運用體內的鈣,進而確保有足夠的鈣質代謝以支援動脈與骨骼健康。此現象通常稱為鈣反常。
鈣反常可以簡單解釋為,把鈣放在正確的地方(例如,把鈣存放於骨骼結構中,而非動脈血管壁)。維他命K2促進參與鈣質運用的蛋白質合成,因此可支援鈣的骨內滯留與動脈健康。特殊抑長基因6蛋白質(Gas6)是一種依賴維他命K的蛋白質,存在於整個神經系統,以及心臟、肺、胃、腎臟與軟骨。雖然其作用的確切運作機制尚未確定,但Gas6似乎是一個細胞生長的調節劑,參與細胞活動,如細胞粘附、細胞增生和防止細胞凋亡。
常見問答
為何加入維他命K在Isotonix維他命D+K2沖飲?
本產品中加入維他命K因為維他命K和D配合使用成效顯著,能共同支援鈣的吸收和運用。維他命K支援鈣輸送到骨骼,並有助維持動脈健康。
Isotonix維他命D+K2沖飲對服用抗凝血藥物的人是否安全?
研究表示維他命K2不會對抗凝血藥物造成影響。不過,大多數含有維他命K(包括K1及/或K2)的產品都有警告標示,提醒服用抗凝血藥物人士不要使用此類產品。如果你正在服用薄血丸或其他抗凝血藥物,在使用任何含有維他命K1或K2的產品前,請先諮詢你的醫護人員。
如何使用Isotonix維他命D+K2沖飲?
將一小瓶蓋量(白色螺旋蓋)的粉末倒入透明瓶杯中。加水至瓶杯線上(60毫升),攪拌後飲用。作為營養補充品,每日飲用一次,或按你的醫護人員的指示飲用。隨餐一起食用,吸收效果最佳。
每天使用本產品多於一份食用量是否安全?
Isotonix維他命D+K2沖飲建議每日食用一份。如果要食用更多的份量,請先諮詢你的醫護人員。
維他命D可以從哪些食物中攝取?
鱈魚肝油、鮭魚、鯖鱼和吞拿魚皆富含維他命D。
此產品安全並不含有害物質。本產品在美國製造,並經美國食品及藥物管理局檢測設備生產,符合生產規範。
科學
- Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. International Immunopharmacology. 2(7):1017-1028, 2002.
- American Journal of Epidemiology. 168(8):915-24, 2008. · Deluca H et al. Vitamin D: its role and uses in immunology. FASEB Journal. 15(14):2579-2585, 2001.
- Argiles A et al. Blood pressure is correlated with vitamin D(3) serum levels in dialysis patients. Blood Purification. 20(4):370-375, 2002.
- Bekner K. The vitamin K-dependent carboxylase. Journal of Nutrition. 130(8):1877-1880, 2000.
- Binkley N et al. Vitamin K nutrition and osteoporosis. Journal of Nutrition. 125(7):1812-1821, 1995.
- Bischoff-Ferrari Het al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 293(18):2257-2264, 2005.
- Blackmore K et al. Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer.
- Cantorna M et al. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Experimental Biology and Medicine ( Maywood ). 229(11):1136-1142, 2004.
- Cantorna M. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Society for Experimental Biology and Medicine. 223:230-233, 2000.
- Chapuy M et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. New England Journal of Medicine. 327(23):1637-1642, 1992.
- Chlebowski R et al. Vitamin K in the treatment of cancer. Cancer Treatment Review. 12:49-63, 1985.
- Garber, A. K., et al. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. Journal of Nutrition. 129(6):1201-1203, 1999.
- Garland C et al. The role of vitamin D in cancer prevention. American Journal of Public Health. 96(2):252-61, 2006.
- Giovannucci E et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. Journal of the National Cancer Institute. 98(7):451-459, 2006.
- Gorham E et al. Vitamin D and prevention of colorectal cancer. Journal Steroid Biochemistry and Molecular Biology. 97(1-2):179-94, 2005.
- Grant W and Holick M. Benefits and requirements of vitamin D for optimal health. Alternative Medicine Review. 10:94-111, 2005.
- Grant W et al. Reviews: A critical review of studies on vitamin D in relation to colorectal cancer. Nutrition and Cancer. 48(2):115-123, 2004.
- Guirguis-Blake J et al. Oral vitamin D3 decreases fracture risk in the elderly. Journal of Family Practice. 52(6):431-435, 2003.
- Gundberg C et al. Vitamin K status and bone health: an analysis of methods for determination under carboxylated osteocalcin. Journal of Clinical Endocrinology and Metabolism. 83(9):3258-3266, 1998.
- Habu D et al. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA. 292(3):358-361, 2004.
- Harris D et al. Vitamin D and colon carcinogenesis. Journal of Nutrition. 134(12):3463S-3471S, 2004.
- Hayes C et al. The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology. 49(2):277-300, 2003.
- Hidaka T et al. Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: effects of concomitant administration of vitamin K(2). Journal of Bone and Mineral Metabolism. 20(4):235-239, 2002.
- Hiruma Y et al. Vitamin K(2) and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner. Biochemical Biophysical Research Communications. 314(1):24-30, 2004.
- Hitomi M et al. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. International Journal of Oncology. 26(3):713-720, 2005.
- Holick, M. Vitamin D: Its role in cancer prevention and treatment. Progress in Biophysics and Molecular Biology. 92(1):49-59, 2006.
- Iwamoto J et al. Effects of vitamin K2 on osteoporosis. Current Pharmaceutical Design. 10(21):2557-2576, 2004.
- Iwamoto J et al. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis. The Keio Journal of Medicine. 2003 Sep;52(3):147-50. Review. · Neogi, T., et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis and Rheumatism. 54(4):1255-1261, 2006.
- Kameda T et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochemical and Biophysical Research Communications. 220(3):515-519, 1996.
- Knapen M et al. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporosis International. 18(7):963-72, 2007.
- Kristal-Boneh E et al. Association of calcitriol and blood pressure in normotensive men. Hypertension. 30(5):1289-1294, 1997.
- Li Y et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation. 110(2):229-238, 2002.
- Li Y et al. Vitamin D regulation of the renin-angiotensin system. Journal of Cell Biochemistry. 88(2):327-331, 2003.
- Li Y et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5):387-392, 2004.
- Nelsestuen G et al. Vitamin K-dependent proteins. Vitamins and Hormones. 58:355-389, 2000.
- Nimptsch K et al. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition. American Journal of Clinical Nutrition. 87:985-992, 2008.
- Nouso K et al. Regression of hepatocellular carcinoma during vitamin K administration. World Journal of Gastroenterology. 11(42):6722-6724, 2005.
- Pfeifer M et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. Journal of Clinical Endocrinology and Metabolism. 86(4):1633-1637, 2001.
- Price P. Role of vitamin K-dependent proteins in bone metabolism. Annual Review of Nutrition. 8:565-583, 1988.
- Schaafsma, A., et al. Vitamin D3 and vitamin K1 supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. European Journal of Clinical Nutrition. 54:626-631, 2000.
- Schleithoff S et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition. 83(4):754-759, 2006.
- Shearer M. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Current Opinion in Clinical Nutrition and Metabolic Care. 3(6):433-438, 2000.
- Shiraki, M., et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. Journal of Bone & Mineral Research. 15:515-522, 2000.
- Sigmund C. Regulation of renin expression and blood pressure by vitamin D(3). Journal of Clinical Investigation. 110(2):155-156, 2002.
- Taira H et al. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors. Calcified Tissue International. 73(1):78-85, 2003.
- Trivedi Det al. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal. 326(7387):469, 2003.
- Van den Berghe G et al. Bone turnover in prolonged critical illness: effect of vitamin D. Journal of Clinical Endocrinology and Metabolism. 88(10):4623-4632, 2003.
- Vasquez A et al. The clinical importance of vitamin D (cholecalciferol): a paradigm shift with implications for all healthcare providers. Alternative Therapies. 10(5):28-38, 2004.
- Weber P. Management of osteoporosis: is there a role for vitamin K? International Journal for Vitamin and Nutrition Research. 67(5):350-6, 1997.
- Yokoyama T et al. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines. International Journal of Oncoloy. 26(1):33-40, 2005.
- Yoshida T et al. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. International Journal of Oncology. 23(3):627-632, 2003.
- Zitterman A et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology. 41(1):105-112, 2003.
評價
顧客評分
4.6 星級評分(滿分為5星)。
(12 評論)
將會推薦此產品。
- 最高評價
- 最低評價
- 最新
- 最舊
- 最有幫助
這罐一定要空腹喝嗎?能否餐後?(查到維生素D任何時間服用都可以,餐後喝效果最好)
客戶服務部回覆 日期 16/5/2022
感謝您聯絡美安公司。愛尚它®維生素D3 (含維生素K2)粉末建議用餐時飲用。提供您參考,謝謝您。
消費者認為此評論有幫助
此產品幾歲小孩可以吃
作者 匿名
日期 5/5/2022
請問11歲孩童可以喝嗎?是否喝的量跟成人一樣?
客戶服務部回覆 日期 16/5/2022
感謝您聯絡美安公司。愛尚它®維生素D3 (含維生素K2)粉末是針對十八歲以上成人而設計。兒童則建議您可參考愛的奇蹟™系列,此系列是專為寶寶、兒童、及準媽媽們所設計的高品質護膚產品與營養補充食品。提供您參考。
Isotonix 維他命D+K2沖飲
作者 匿名
日期 25/11/2020
醫生提醒我骨質指數要注意, 建議多曬太陽, 否則中年後好易有骨質疏鬆。於是我開始食這款維他命D 及鈣, 2個月後再去檢查, 醫生竟然話指數回復正常, 不用再覆診。2個月時間比我預期少, 加鈣原來幫助更事半功倍。
客戶服務部回覆 日期 25/11/2020
致 親愛的顧客,
感謝您抽出寶貴時間對Isotonix®維他命D+K2沖飲發表意見。 我們很高興您對產品感到滿意。
再次感謝閣下對美安的支持!
超連鎖店主服務部 謹啟
Isotonix
作者 JEFFERYS
購物顧問
購物顧問是本產品的獨立經銷商。
日期 5/3/2024
This is a great product, It helps me every day with more Energy and keeps me going!!!
客戶服務部回覆 日期 6/3/2024
Dear Valued Customer,
Thank you for sharing your positive feedback with us! We're delighted to hear that you're enjoying the Isotonix® Vitamin D with K2 and experiencing the great benefits. Your feedback means a lot to us and it's always great to receive such kind words. If you have any questions or need further assistance, feel free to reach out to us anytime.
Thank you again,
The Product Information Team
Frist time using this and I just love it.
作者 SharonS
日期 16/2/2023
Love this product and i can see the different right away, and it taste good.
客戶服務部回覆 日期 17/2/2023
Dear Valued Customer,
Thank you for taking the time to share your thoughts on the Isotonix® Vitamin D with K2! We are so happy to hear you are pleased with the product!
Thank you again!
The Product Information Team
消費者認為此評論有幫助
Share this page!
複製此連結並貼上到你喜愛的社交媒體、網誌或網站。
成功!你已複製連結至你的剪貼簿
There was an error copying to your clipboard. Please try again later.